scPharmaceuticals Ownership | Who Owns scPharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

scPharmaceuticals Ownership Summary


scPharmaceuticals is owned by 83.80% institutional investors, 11.40% insiders, and 4.81% retail investors. Orbimed advisors is the largest institutional shareholder, holding 13.01% of SCPH shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.27% of its assets in scPharmaceuticals shares.

SCPH Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockscPharmaceuticals83.80%11.40%4.81%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Orbimed advisors6.06M13.01%$21.45M
Rubric capital management lp4.78M10.26%$16.90M
Aigh capital management4.17M8.97%$14.78M
King luther capital management2.86M6.14%$10.12M
Blackrock funding, inc. /de2.28M4.90%$8.08M
Blackrock1.77M4.54%$7.69M
Vanguard group2.11M4.53%$7.46M
Suvretta capital management1.84M3.95%$6.52M
J. goldman & co lp1.22M2.62%$4.32M
5am venture management1.20M2.58%$4.25M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Aigh capital management4.17M4.62%$14.78M
Stonepine capital management683.53K1.95%$2.42M
Tejara capital612.85K1.42%$2.17M
5am venture management1.20M1.01%$4.25M
Apis capital advisors394.00K0.93%$1.39M
Orbimed advisors6.06M0.44%$21.45M
Kingdon capital management800.00K0.40%$2.83M
Suvretta capital management1.84M0.22%$6.52M
Rubric capital management lp4.78M0.22%$16.90M
Balanced rock investment advisor70.36K0.20%$249.08K

Top Buyers

HolderShares% AssetsChange
Ubs group1.04M0.00%1.02M
King luther capital management2.86M0.04%632.12K
Perceptive advisors500.00K0.05%500.00K
Blackrock funding, inc. /de2.28M0.00%429.42K
Vanguard group2.11M0.00%399.51K

Top Sellers

HolderShares% AssetsChange
Velan capital investment management lp---517.67K
Walleye capital---475.56K
Bank of montreal /can/---351.81K
Monashee investment management---319.80K
Adage capital partners gp---249.26K

New Positions

HolderShares% AssetsChangeValue
Perceptive advisors500.00K0.05%500.00K$1.77M
Raymond james financial89.69K0.00%89.69K$317.50K
Johnson financial group85.18K0.04%85.18K$301.55K
Price t rowe associates inc /md/15.14K-15.14K$54.00K
Proshare advisors13.46K0.00%13.46K$47.67K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-6.00
Farther finance advisors-59.00
Capital performance advisors llp-85.00
Covestor-151.00
Gamma investing-265.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202482-16.33%39,015,4824.73%831.31%49-19.67%16-15.79%
Sep 30, 20249721.25%37,237,61933.87%791.57%6046.34%19-20.83%
Jun 30, 202479-2.47%27,815,2484.03%711.50%4117.14%23-23.33%
Mar 31, 202481-4.71%26,737,984-4.32%681.33%35-16.67%3020.00%
Dec 31, 20238510.39%27,946,038-6.54%721.21%4240.00%25-10.71%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.14M2.27%-
Vanguard US Total Market Shares ETF1.14M2.26%-
iShares Russell 2000 ETF953.85K1.90%-8.25K
Vanguard Institutional Extnd Mkt Idx Tr622.22K1.24%-
Fidelity Small Cap Index369.84K0.74%-6.93K
iShares Russell 2000 Growth ETF335.28K0.67%-1.60K
Kennedy Micro Cap218.81K0.44%1.05K
State St Russell Sm/Mid Cp® Indx NL Cl C212.85K0.42%-
State St Russell Sm/Mid Cp® Indx SL Cl I212.85K0.42%-
Thrivent Small Cap Growth S183.16K0.36%1.38K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 13, 2024ORBIMED ADVISORS LLC-Buy$86.63K
Aug 13, 2024ORBIMED ADVISORS LLC-Buy$1.91M
Nov 25, 2022ORBIMED ADVISORS LLC-Buy$4.00M
Oct 06, 20225AM Partners IV, LLC-Sell$152.89K
Oct 06, 2022Schwab Andrew J.-Sell$152.89K

Insider Transactions Trends


DateBuySell
2025 Q1--
2024 Q32-
2024 Q2--
2024 Q1--
2023 Q2--

SCPH Ownership FAQ


Who Owns scPharmaceuticals?

scPharmaceuticals shareholders are primarily institutional investors at 83.80%, followed by 11.40% insiders and 4.80% retail investors. The average institutional ownership in scPharmaceuticals's industry, Biotech Stocks , is 68.48%, which scPharmaceuticals exceeds.

Who owns the most shares of scPharmaceuticals?

scPharmaceuticals’s largest shareholders are Orbimed advisors (6.06M shares, 13.01%), Rubric capital management lp (4.78M shares, 10.26%), and Aigh capital management (4.17M shares, 8.97%). Together, they hold 32.24% of scPharmaceuticals’s total shares outstanding.

Does Blackrock own scPharmaceuticals?

Yes, BlackRock owns 4.54% of scPharmaceuticals, totaling 1.77M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 7.69M$. In the last quarter, BlackRock decreased its holdings by -32.941K shares, a -1.83% change.

Who is scPharmaceuticals’s biggest shareholder by percentage of total assets invested?

Aigh capital management is scPharmaceuticals’s biggest shareholder by percentage of total assets invested, with 4.62% of its assets in 4.17M scPharmaceuticals shares, valued at 14.78M$.

Who is the top mutual fund holder of scPharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of scPharmaceuticals shares, with 2.27% of its total shares outstanding invested in 1.14M scPharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools